Cartesian Therapeutics, Inc.
RNAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001453687
No open-market purchases or sales by Cartesian Therapeutics, Inc. insiders were filed in the last 90 days; 94 institutions reported holding it in 13F filings for Q2 2026, worth $90.4M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Cartesian Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 64
- +3 vs. Q2 2024
- Shares held
- 6.87M
- +4.00M (+139.8%) vs. Q2 2024
- Total value
- $110.3M
- +$33.1M (+42.8%) vs. Q2 2024
- New holders
- 16
- 20 more added
- Sold out
- 13
- 10 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RNAC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 94 | $90.4M |
| Q1 2026 | 83 | $43.9M |
| Q4 2025 | 67 | $37.2M |
| Q3 2025 | 68 | $60.9M |
| Q2 2025 | 66 | $66.5M |
| Q1 2025 | 72 | $86.7M |
| Q4 2024 | 68 | $119.5M |
| Q3 2024 | 64 | $110.3M |
| Q2 2024 | 62 | $88.3M |
| Q1 2024 | 70 | $35.3M |
| Q4 2023 | 80 | $37.8M |
| Q3 2023 | 87 | $57.2M |
| Q2 2023 | 92 | $63.2M |
| Q1 2023 | 95 | $65.1M |
| Q4 2022 | 86 | $62.8M |
| Q3 2022 | 97 | $104.9M |
| Q2 2022 | 93 | $79.3M |
| Q1 2022 | 102 | $71.6M |
| Q4 2021 | 106 | $185.7M |
| Q3 2021 | 103 | $216.7M |
| Q2 2021 | 101 | $219.2M |
| Q1 2021 | 98 | $245.1M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Cartesian Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 2,851,830 | $46.0M | 0.00% | +2,341,054+458.3% | Added |
| MPM Oncology Impact Management LP | 629,423 | $10.1M | 1.52% | +369,727+142.4% | Added |
| Siren, L.L.C. | 572,236 | $9.22M | 0.46% | +572,236 | New |
| BlackRock, Inc. | 423,466 | $6.83M | 0.00% | +423,466 | New |
| Citadel Advisors LLC | 375,767 | $5.76M | 0.01% | +375,767 | New |
| JPMorgan Chase & Co | 309,018 | $4.98M | 0.00% | +2,688+0.9% | Added |
| Vanguard Group Inc | 243,089 | $3.92M | 0.00% | +6,432+2.7% | Added |
| Great Point Partners LLC | 200,000 | $3.22M | 0.97% | +200,000 | New |
| Erste Asset Management GmbH | 173,566 | $2.80M | 0.03% | +51,333+42.0% | Added |
| State Street Corp | 157,495 | $2.54M | 0.00% | +3,830+2.5% | Added |
| Geode Capital Management, LLC | 135,700 | $2.19M | 0.00% | +2,737+2.1% | Added |
| Yale University | 100,000 | $1.61M | 66.30% | 00.0% | Unchanged |
| Armistice Capital, LLC | 98,565 | $1.59M | 0.04% | +98,565 | New |
| 683 Capital Management, LLC | 75,431 | $1.22M | 0.12% | +75,431 | New |
| Northern Trust Corp | 63,115 | $1.02M | 0.00% | +32,191+104.1% | Added |
| Ikarian Capital, LLC | 52,193 | $841.4K | 0.26% | −190,177−78.5% | Reduced |
| Schonfeld Strategic Advisors LLC | 50,000 | $797.9K | 0.01% | +50,000 | New |
| Balyasny Asset Management LLC | 49,497 | $797.9K | 0.00% | +49,497 | New |
| Freestone Capital Holdings, LLC | 25,921 | $417.8K | 0.01% | +17,921+224.0% | Added |
| Nuveen Asset Management, LLC | 24,210 | $390.3K | 0.00% | −10,540−30.3% | Reduced |
| Delphi Financial Group, Inc. | 22,028 | $355.1K | 0.20% | 00.0% | Unchanged |
| Morgan Stanley | 22,011 | $354.8K | 0.00% | +14,764+203.7% | Added |
| Charles Schwab Investment Management Inc | 19,048 | $307.1K | 0.00% | 00.0% | Unchanged |
| Lake Street Advisors Group, LLC | 15,822 | $255.1K | 0.01% | −15,822−50.0% | Reduced |
| Bank of New York Mellon Corp | 15,102 | $243.4K | 0.00% | −4,814−24.2% | Reduced |
| Ironwood Investment Management LLC | 14,631 | $235.9K | 0.11% | +14,631 | New |
| Boothbay Fund Management, LLC | 14,518 | $234.0K | 0.01% | −54,022−78.8% | Reduced |
| Two Sigma Investments, LP | 12,911 | $208.1K | 0.00% | +12,911 | New |
| Twin Focus Capital Partners, LLC | 12,000 | $193.4K | 0.03% | +2,000+20.0% | Added |
| Barclays PLC | 11,611 | $187.2K | 0.00% | +7,849+208.6% | Added |
| Goldman Sachs Group Inc | 11,336 | $182.7K | 0.00% | +11,336 | New |
| Squarepoint Ops LLC | 10,393 | $167.5K | 0.00% | +10,393 | New |
| Bridgeway Capital Management, LLC | 10,193 | $164.3K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 9,274 | $149.5K | 0.00% | +787+9.3% | Added |
| Bank of America Corp | 7,570 | $122.0K | 0.00% | +2,314+44.0% | Added |
| UBS Group AG | 5,339 | $86.1K | 0.00% | +3,102+138.7% | Added |
| Citigroup Inc | 5,217 | $84.1K | 0.00% | +3,645+231.9% | Added |
| New York State Common Retirement Fund | 5,102 | $82.2K | 0.00% | 00.0% | Unchanged |
| Johnson Financial Group, Inc. | 4,618 | $74.4K | 0.00% | +4,618 | New |
| Mirae Asset Global ETFs Holdings Ltd. | 3,997 | $64.4K | 0.00% | +2,370+145.7% | Added |
| Corebridge Financial, Inc. | 3,864 | $62.3K | 0.00% | −24−0.6% | Reduced |
| Deutsche Bank AG | 3,638 | $58.6K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2,938 | $47.0K | 0.00% | +125+4.4% | Added |
| Wells Fargo & Company | 2,279 | $36.7K | 0.00% | −88−3.7% | Reduced |
| Hall Laurie J Trustee | 1,759 | $28.0K | 0.01% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 1,761 | $28.0K | 0.00% | +1,761 | New |
| BNP Paribas Arbitrage, SA | 1,651 | $26.6K | 0.00% | +909+122.5% | Added |
| Legal & General Group Plc | 801 | $12.9K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 708 | $11.4K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 567 | $9.14K | 0.00% | −1,198−67.9% | Reduced |
| California State Teachers Retirement System | 524 | $8.45K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 234 | $3.77K | 0.00% | −62−20.9% | Reduced |
| Amalgamated Bank | 130 | $2.00K | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 66 | $1.06K | 0.00% | 00.0% | Unchanged |
| Mirae Asset Global Investments Co., Ltd. | 3,715 | $669 | 0.00% | 00.0% | Unchanged |
| WR Wealth Planners, LLC | 39 | $629 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 18 | $290 | 0.00% | 00.0% | Unchanged |
| SRS Capital Advisors, Inc. | 12 | $194 | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 11 | $177 | 0.00% | −3−21.4% | Reduced |
| Sterling Capital Management LLC | 7 | $113 | 0.00% | +7 | New |
| Parallel Advisors, LLC | 3 | $48 | 0.00% | 00.0% | Unchanged |
| Hazlett, Burt & Watson, Inc. | 12 | $0 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 16 | $0 | 0.00% | +12+300.0% | Added |
| CoreCap Advisors, LLC | 1 | $0 | 0.00% | +1 | New |
| Artal Group S.A. | 0 | $0 | 0.00% | −304,554−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −90,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −30,038−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −25,070−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −17,052−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −13,010−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −2,838−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −1,824−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −1,725−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −152−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |